United States Viral Inactivation Market 2025 | Growth Drivers, Key Players & Investment Opportunities

Market Size and Growth

Viral Inactivation Market is expected to grow at a CAGR of 11.0% during the forecast period (2024-2031).

Key Development:

United States: Recent Industry Developments

✅ In May 2025, the U.S. Centers for Disease Control and Prevention (CDC) reported an increase in tuberculosis cases from 8,320 in 2022 to 9,615 in 2023, representing an increase of 1,295 cases. The incidence rate also rose from 2.5 per 100,000 individuals in 2022 to 2.9 in 2023.

✅ In March 2025, the U.S. Food and Drug Administration (FDA) approved a new viral inactivation method for plasma-derived therapies, enhancing safety protocols in the biopharmaceutical industry.

✅ In February 2025, the National Institutes of Health (NIH) awarded grants to several biotech firms for the development of next-generation viral inactivation technologies aimed at improving the safety of gene therapies.

Japan: Recent Industry Developments

✅ In July 2025, Japan's Ministry of Health, Labour and Welfare announced a significant investment in the development of advanced viral inactivation technologies for blood products, aiming to enhance safety measures in the healthcare sector.

✅ In June 2025, a consortium of Japanese pharmaceutical companies initiated a collaborative project to develop a novel viral inactivation system for cell-based therapies, with trials expected to commence by the end of the year.

✅ In May 2025, the Japanese government launched a national initiative to standardize viral inactivation procedures across medical institutions, ensuring uniform safety protocols nationwide.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/viral-inactivation-market?sb

Viral inactivation is the process of neutralizing or destroying viruses to prevent infection and ensure the safety of vaccines, biologics, and blood products. It employs chemical, thermal, or radiation-based methods to eliminate viral activity while preserving the efficacy of the treated product.

Recent Mergers and acquisitions:

United States: Recent Mergers & Acquisitions

✅ In July 2025, Merck & Co. announced its acquisition of Verona Pharma for $10 billion. This strategic move enhances Merck's respiratory pipeline, particularly in the development of therapies targeting chronic obstructive pulmonary disease (COPD).

✅ In June 2025, Thermo Fisher Scientific completed the acquisition of Clean Cells, a France-based provider of viral clearance testing services. This acquisition strengthens Thermo Fisher's capabilities in ensuring the safety of biologic therapies.

✅ In May 2025, Charles River Laboratories acquired WuXi AppTec's viral inactivation services division. This acquisition expands Charles River's offerings in viral safety testing for cell and gene therapies.

Japan: Recent Mergers & Acquisitions

✅ In August 2025, Takeda Pharmaceutical Company announced the acquisition of a majority stake in a Japanese biotech firm specializing in viral inactivation technologies for plasma-derived therapies. This acquisition aims to enhance Takeda's capabilities in ensuring the safety of its blood products.

✅ In July 2025, Mitsubishi Chemical Corporation completed the acquisition of a viral inactivation technology company. This strategic move strengthens Mitsubishi Chemical's position in the healthcare sector, particularly in the development of safe and effective biologic therapies.

✅ In June 2025, Daiichi Sankyo Company announced the acquisition of a Japanese startup specializing in viral clearance technologies. This acquisition aims to bolster Daiichi Sankyo's capabilities in ensuring the safety of its biologic drug portfolio.

Key Players:

=> Charles River Laboratories International, Inc., Clean Cells Inc., Danaher Corporation, Cerus Corporation, Parker Hannifin Corporation, Merck KGaA, Rad Source Technologies, Inc., Sartorius AG, SGS SA, and Wuxi Pharmatech (Cayman) Inc.

Growth Forecast Projected:

The Global Viral Inactivation Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Viral Inactivation Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=viral-inactivation-market

Key Segments:

➥ By Method: Solvent Detergent Method, Pasteurization, Others
➥ By Product: Kits & Reagents, Services, Viral Inactivation Systems & Accessories
➥ By Application: Vaccines & Therapeutics, Blood & Blood Products, Cellular & Gene Therapy Products, Tissues & Tissue Products, Stem Cell Products
➥ By End Users: Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Others

Regional Analysis for Viral Inactivation Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Viral Inactivation producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Viral Inactivation revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/viral-inactivation-market?sb

FAQ

Q: What is the growth rate of the Viral Inactivation Market?

A: The market is projected to expand at a compound annual growth rate (CAGR) of 11.0% during the forecast period from 2024 to 2031.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.